Chapter 26. PET ligands for assessing receptor occupancy in vivo

被引：2

作者：

Burns, HD ^{[1
]}

Hamill, TG ^{[1
]}

Eng, WS ^{[1
]}

Hargreaves, R ^{[1
]}

机构：

[1] Merck Res Labs, Dept Pharmacol, West Point, PA 19486 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36 | 2001年 / 36卷

关键词：

D O I：

10.1016/S0065-7743(01)36066-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：267 / 276

页数：10

共 62 条

[1] Use of PET and the radioligand [Carbonyl-11C]WAY-100635 in psychotropic drug development [J].

Andrée, B ;

Halldin, C ;

Thorberg, SO ;

Sandell, J ;

Farde, L .

NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (05) :515-521

[2] Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 -: PET studies in rhesus monkey [J].

Bergström, M ;

Fasth, KJ ;

Kilpatrick, G ;

Ward, P ;

Cable, KM ;

Wipperman, MD ;

Sutherland, DR ;

Langström, B .

NEUROPHARMACOLOGY, 2000, 39 (04) :664-670

[3]

BURNS D, 1999, AM COLL NEUR M

[4] Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development [J].

Burns, HD ;

Hamill, TG ;

Eng, W ;

Francis, B ;

Fioravanti, C ;

Gibson, RE .

CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :388-394

[5]

BURNS HD, 1996, NUCL MED PRINCIPLES, V2, P1273

[6]

BURNS HD, 1993, NUCL IMAGING DRUG DI

[7]

Campbell D B, 1997, Q J Nucl Med, V41, P163

[8]

CAMPBELL DB, 1997, DRUG INF J, V31, P989

[9] PET evaluation of [18F]FCWAY, an analog of the 5-HT1A receptor antagonist, WAY-100635 [J].

Carson, RE ;

Lan, LX ;

Watabe, H ;

Der, MG ;

Adams, HR ;

Jagoda, E ;

Herscovitch, P ;

Eckelman, WC .

NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (05) :493-497

[10]

CHERRY SR, 1998, QUANTITATIVE FUNCTIO

← 1 2 3 4 5 6 7 →